SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-21-138560
Filing Date
2021-04-29
Accepted
2021-04-29 09:04:52
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A d41208ddefa14a.htm DEFA14A 16053
2 GRAPHIC g41208page004.jpg GRAPHIC 203106
3 GRAPHIC g41208page005.jpg GRAPHIC 80413
  Complete submission text file 0001193125-21-138560.txt   397821
Mailing Address 26 LANDSDOWNE STREET CAMBRIDGE MA 02139
Business Address 26 LANDSDOWNE STREET CAMBRIDGE MA 02139 617-651-8851
Fulcrum Therapeutics, Inc. (Filer) CIK: 0001680581 (see all company filings)

IRS No.: 474839948 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38978 | Film No.: 21867412
SIC: 2834 Pharmaceutical Preparations